






| Ingredient | Biochemical Form | Buyer Evaluation Focus |
|---|---|---|
| Coenzyme Q10 (Ubiquinone) | Oxidized CoQ10 | Confirm ubiquinone identity, assay basis, composition, and behavior in the intended formulation. |
| Ubiquinol (Reduced CoQ10) | Reduced CoQ10 | Confirm the measured reduced-form content, oxidation controls, and documented handling requirements. |




| Ingredient | Biochemical Distinction | Procurement Consideration |
|---|---|---|
| NAD+ | Oxidized nicotinamide adenine dinucleotide | Confirm exact identity, supplied chemical form, assay method, and relevant stability data. |
| NADH | Reduced nicotinamide adenine dinucleotide | Review reduced-form assay, oxidation-related changes, and documented storage and packaging conditions. |
| NMN (Nicotinamide Mononucleotide) | NAD-related precursor | Confirm the specified molecular identity, analytical evidence, and status for the intended market and use. |


| Comparison Area | What Buyers Should Establish |
|---|---|
| Identity and form | The named compound, redox state, and applicable salt or molecular form. |
| Assay and composition | What the method measures, the reporting basis, and any declared carriers. |
| Physical properties | Relevant moisture, particle characteristics, and handling parameters for the selected material. |
| Solubility and dispersion | Behavior at the intended concentration, pH, and temperature, supported by applicable data. |
| Stability | Retention of the specified form under proposed processing and storage conditions. |
| Formulation compatibility | Interactions with excipients and other actives in the intended dosage form. |
| Analytical evidence | Methods and results that support identity, content, and relevant impurity limits. |

A cofactor is a non-protein component required for an enzyme’s activity. Cofactors include organic molecules and metal ions. Coenzymes are organic cofactors involved in enzyme-catalyzed reactions; the term describes a narrower biochemical group.
No. NAD+ is the oxidized form of nicotinamide adenine dinucleotide; NADH is the reduced form. Buyers should evaluate their identities, assays, and handling requirements separately before considering either material for a formulation.
Check exact identity, redox form where relevant, assay basis, composition, batch evidence, and stability information. Confirm that analytical methods and documented handling conditions support your intended formulation and incoming-material acceptance criteria.
No. Specialty nutrients is a commercial grouping that can include coenzymes, methyl donors, phospholipid intermediates, and nucleosides. Each compound retains its own biochemical identity and requires an ingredient-specific specification.
Include the ingredient name and form, intended application, target assay and acceptance limits, required documentation, estimated quantity, and destination market. Add processing or storage constraints that could affect material selection.